Bioreactors Market Is Expected Grow at a CAGR of 11% During the Forecast Period 2023-2030
Merck announced the purchase of Lonza's MAST platform, an automated aseptic bioreactor sampling system, in 2022. Customers can use these systems to optimise data during bioprocessing. This purchase will help the firm increase its market footprint
View full press release